Discover 3,059 paid clinical trials in Pennsylvania. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Pennsylvania provides numerous options to healthy volunteers looking to take part in paid research studies, as well as participants looking for condition-specific trials. Research hubs in Philadelphia, Pittsburgh, and Allentown are actively recruiting participants, giving access to groundbreaking treatments and quality healthcare.
Filter
1
Filter results
Results: 3,059
A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy
for
Symptomatic Genetic Dilated Cardiomyopathy
Location: Boston MA, New York NY, Philadelphia PA, Baltimore MD,
Sponsor: Kardigan, Inc.
Sex: All
Age: 18+
Code: NCT07210723
Phase 2, Phase 3, Recruiting
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
for
Generalized Myasthenia Gravis
Location: Philadelphia PA, Chicago IL, Austin TX, Seattle WA
Sponsor: Amgen
Sex: All
Age: 2 - 17
Code: NCT06987539
Phase 2, Recruiting
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
for
Ovarian Neoplasms, Breast Neoplasms,
Location: Boston MA, New York NY, Philadelphia PA, Glen Burnie MD,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07213791
Phase 1, Recruiting
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
for
Type 2 Diabetes
Location: Quebec, Brooklyn NY, Montreal, Morehead City NC,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07754461
Phase 3, Recruiting
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
for
Atherosclerosis, Coronary Artery Disease
Location: Camp Hill PA, Hialeah FL, St. Petersburg FL,
Sponsor: Beijing Inno Medicine Co., Ltd.
Sex: All
Age: 18 - 70+
Code: NCT07521007
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Augmented Reality-Cardiopulmonary Resuscitation Support for Pediatric Resuscitation
Location: Providence RI, New York NY, Philadelphia PA,
Sponsor: Johns Hopkins University
Sex: All
Age: 18+
Code: NCT07778823
Recruiting
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Brewer ME, Rockport ME, Brunswick ME, South Portland ME,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06876714
Phase 3, Recruiting
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
for
Castration-Resistant Prostatic Cancer, Metastasis
Location: Sherbrooke, New York NY, Montreal, Washington D.C. DC,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06863272
Phase 1, Phase 2, Recruiting
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
for
Castration-Sensitive Prostate Carcinoma,
Location: Stony Brook NY, Commack NY, Berlin Corners VT,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: Male
Age: 18+
Code: NCT06931340
Phase 3, Recruiting
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
for
Buccal Mucosa Squamous Cell Carcinoma,
Location: New Haven CT, Lebanon NH, Commack NY, Trumbull CT,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT04333537
Phase 2, Phase 3, Recruiting
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Boston MA, New York NY, Hackensack NJ,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06973187
Phase 3, Recruiting
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
for
Geographic Atrophy (GA),
Location: Waterford CT, Springfield MA, Westbury NY, Oceanside NY,
Sponsor: ONL Therapeutics
Sex: All
Age: 55+
Code: NCT06659445
Phase 2, Recruiting
Minima Stent System Post- Approval Study (PAS)
for
Pulmonary Artery Stenosis, Aortic Coarctation
Location: Boston MA, Charlottesville VA, Miami FL, Pittsburgh PA,
Location: Portland ME, Fall River MA, Providence RI, New York NY,
Sponsor: Philips Clinical & Medical Affairs Global
Sex: All
Age: 18+
Code: NCT05916950
Recruiting
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
for
Non-Small-Cell Lung Cancer,
Location: Lake Success NY, New York NY, Philadelphia PA, Ottawa,
Sponsor: ArriVent BioPharma, Inc.
Sex: All
Age: 18+
Code: NCT07185997
Phase 3, Recruiting
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)